title: Differential function of protective agents at each stage of the hypothermic preservation of hepatocytes.
abstract: Hypothermic preservation of bioartificial liver (BAL) has long been appreciated in BAL storage and transportation. However, the deterioration of cell activity during hypothermia/rewarming limits its clinical use and the complete prevention of hypothermia-induced hepatocyte injury has not been achieved. In this article, a miniaturized BAL that underwent three preservation stages (i.e. pre-incubation, hypothermia and rewarming) was applied as a hypothermic preservation model to locate the protection of several protective agents against hypothermia-induced cell injury. The agents, including vitamin E, schisandrin B, glycyrrhizic acid, N-acetyl-cysteine, ruthenium red, trehalose, anisodamine, fructose-1, 6-diphosphate, cyclosporin A and matrine (Mat), were found to exert their functions at different preservation stages, which were speculated to associate with the specific protection of each agent as well as the corresponding cell injuries at each stage. Such hypothesis was further strengthened by focusing on Mat, which only suppressed the hypothermia-induced injury through the inhibition of Ca(2+) overload at the rewarming stage, whereas its presence at the hypothermic stage excessively down-regulated the cytosolic free Ca(2+) and then aggravated cell death. The results indicate that the specific cell injury at each preservation stage requires a corresponding protective agent. However, the untimely misuse of the agents may inversely aggravate cell injury.
authors.affiliation: Department of Chemical and Biological Engineering, Zhejiang University, 38 Zheda Road, Hangzhou, Zhejiang, P.R. China.
authors.forename: Jing
authors.initials: J
authors.lastname: Dai
authors.forename: Qin
authors.initials: Q
authors.lastname: Meng
mesh_terms: D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D019610:Cytoprotection / Q000187:drug effects*; D005635:Fructosediphosphates / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009926:Organ Preservation / Q000379:methods; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012430:Ruthenium Red / Q000494:pharmacology; D012991:Solanaceous Alkaloids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014199:Trehalose / Q000494:pharmacology; D000093842:Matrines
chemical_list: D000470:Alkaloids; D000975:Antioxidants; D005635:Fructosediphosphates; D011807:Quinolizines; D012991:Solanaceous Alkaloids; C003922:anisodamine; D012430:Ruthenium Red; D016572:Cyclosporine; D014199:Trehalose; C029063:fructose-1,6-diphosphate; D002118:Calcium; D000093842:Matrines